Healthcare provider profile · identity verified

James Anthony Brown, M.D.

Family Practice · DETROIT, MI · NPI 1427169242

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Albuterol Sulfate Hfa	Albuterol Sulfate	367	112
Amlodipine Besylate	Amlodipine Besylate	362	113
Atorvastatin Calcium	Atorvastatin Calcium	359	122
Losartan Potassium	Losartan Potassium	325	94
Rosuvastatin Calcium	Rosuvastatin Calcium	291	88
Lisinopril	Lisinopril	163	51
Omeprazole	Omeprazole	162	51
Metoprolol Succinate	Metoprolol Succinate	148	44
Tamsulosin Hcl	Tamsulosin Hcl	126	38
Gabapentin	Gabapentin	125	35
Furosemide	Furosemide	123	43
Metformin Hcl	Metformin Hcl	114	36
Azithromycin	Azithromycin	100	65
Metoprolol Tartrate	Metoprolol Tartrate	99	35
Carvedilol	Carvedilol	96	39
Levothyroxine Sodium	Levothyroxine Sodium	95	24
Prednisone	Prednisone	89	39
Triamcinolone Acetonide	Triamcinolone Acetonide	84	35
Potassium Chloride	Potassium Chloride	82	30
Simvastatin	Simvastatin	77	24
Bumetanide	Bumetanide	73	23
Amoxicillin	Amoxicillin	72	41
Fluticasone Propionate	Fluticasone Propionate	72	34
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	72	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	71	16
Eliquis	Apixaban	68	14
Hydrochlorothiazide	Hydrochlorothiazide	67	28
Mupirocin	Mupirocin	66	33
Nifedipine Er	Nifedipine	66	23
Clopidogrel	Clopidogrel Bisulfate	65	24
Spironolactone	Spironolactone	65	20
Trulicity	Dulaglutide	64	11
Diclofenac Sodium	Diclofenac Sodium	61	40
Montelukast Sodium	Montelukast Sodium	57	17
Pantoprazole Sodium	Pantoprazole Sodium	56	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	17
Farxiga	Dapagliflozin Propanediol	52	suppressed
Cephalexin	Cephalexin	51	36
Famotidine	Famotidine	51	14
Metformin Hcl Er	Metformin Hcl	49	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	21
Doxycycline Monohydrate	Doxycycline Monohydrate	47	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	16
Naproxen	Naproxen	46	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	34
Nitroglycerin	Nitroglycerin	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	14
Ozempic	Semaglutide	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	15
Duloxetine Hcl	Duloxetine Hcl	36	13
Allopurinol	Allopurinol	35	15
Tramadol Hcl	Tramadol Hcl	35	suppressed
Trazodone Hcl	Trazodone Hcl	35	13
Jardiance	Empagliflozin	33	12
Latanoprost	Latanoprost	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Glipizide	Glipizide	26	14
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Cilostazol	Cilostazol	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Linezolid	Linezolid	19	12
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	11
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Clotrimazole	Clotrimazole	17	13
Colchicine	Colchicine	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Ammonium Lactate	Ammonium Lactate	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Travoprost	Travoprost	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Baclofen	Baclofen	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Metronidazole	Metronidazole	15	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Mounjaro	Tirzepatide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Atenolol	Atenolol	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Etravirine	Etravirine	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Isentress	Raltegravir Potassium	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Permethrin	Permethrin	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error